PMID- 22100704 OWN - NLM STAT- MEDLINE DCOM- 20120214 LR - 20211021 IS - 1096-0384 (Electronic) IS - 0003-9861 (Print) IS - 0003-9861 (Linking) VI - 517 IP - 1 DP - 2012 Jan 1 TI - Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia. PG - 53-70 LID - 10.1016/j.abb.2011.11.005 [doi] AB - Acute tubular necrosis is a clinical problem that lacks specific therapy and is characterized by high mortality rate. The ischemic renal injury affects the proximal tubule cells causing dysfunction and cell death after severe hypoperfusion. We utilized a cell-based screening approach in a hypoxia-reoxygenation model of tubular injury to search for cytoprotective action using a library of pharmacologically active compounds. Oxygen-glucose deprivation (OGD) induced ATP depletion, suppressed aerobic and anaerobic metabolism, increased the permeability of the monolayer, caused poly(ADP-ribose) polymerase cleavage and caspase-dependent cell death. The only compound that proved cytoprotective either applied prior to the hypoxia induction or during the reoxygenation was adenosine. The protective effect of adenosine required the coordinated actions of adenosine deaminase and adenosine kinase, but did not requisite the purine receptors. Adenosine and inosine better preserved the cellular ATP content during ischemia than equimolar amount of glucose, and accelerated the restoration of the cellular ATP pool following the OGD. Our results suggest that radical changes occur in the cellular metabolism to respond to the energy demand during and following hypoxia, which include the use of nucleosides as an essential energy source. Thus purine nucleoside supplementation holds promise in the treatment of acute renal failure. CI - Copyright (c) 2011 Elsevier Inc. All rights reserved. FAU - Szoleczky, Petra AU - Szoleczky P AD - CellScreen Applied Research Center, Semmelweis University Medical School, Budapest, Hungary; Department of Anesthesiology, The University of Texas Medical Branch, Galveston, TX 77555-1102, USA. FAU - Modis, Katalin AU - Modis K FAU - Nagy, Nora AU - Nagy N FAU - Dori Toth, Zoltan AU - Dori Toth Z FAU - DeWitt, Douglas AU - DeWitt D FAU - Szabo, Csaba AU - Szabo C FAU - Gero, Domokos AU - Gero D LA - eng GR - R01 GM060915/GM/NIGMS NIH HHS/United States GR - R01GM060915/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20111111 PL - United States TA - Arch Biochem Biophys JT - Archives of biochemistry and biophysics JID - 0372430 RN - 0 (Purine Nucleosides) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - IY9XDZ35W2 (Glucose) RN - K72T3FS567 (Adenosine) RN - S88TT14065 (Oxygen) SB - IM MH - Adenosine/pharmacology MH - Adenosine Triphosphate/metabolism MH - Animals MH - Cell Hypoxia/drug effects MH - Cell Survival/drug effects MH - Cytoprotection/*drug effects MH - Glucose/metabolism MH - Hypoxia/*drug therapy/metabolism/pathology MH - Kidney/*cytology/*drug effects/metabolism/pathology MH - Kidney Tubular Necrosis, Acute/drug therapy/metabolism/pathology MH - LLC-PK1 Cells MH - Oxygen/metabolism MH - Purine Nucleosides/*pharmacology MH - Reperfusion Injury/*drug therapy/metabolism/pathology MH - Swine PMC - PMC4676579 MID - NIHMS338295 EDAT- 2011/11/22 06:00 MHDA- 2012/02/15 06:00 PMCR- 2015/12/11 CRDT- 2011/11/22 06:00 PHST- 2011/08/10 00:00 [received] PHST- 2011/11/01 00:00 [revised] PHST- 2011/11/02 00:00 [accepted] PHST- 2011/11/22 06:00 [entrez] PHST- 2011/11/22 06:00 [pubmed] PHST- 2012/02/15 06:00 [medline] PHST- 2015/12/11 00:00 [pmc-release] AID - S0003-9861(11)00363-8 [pii] AID - 10.1016/j.abb.2011.11.005 [doi] PST - ppublish SO - Arch Biochem Biophys. 2012 Jan 1;517(1):53-70. doi: 10.1016/j.abb.2011.11.005. Epub 2011 Nov 11.